SCHAUMBURG, Ill., Nov. 23 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company with a focus on injectable products, today announced that Jeffery M. Yordon, chief executive officer, founder and chairman of the board of Sagent Pharmaceuticals, will present at the 21st Annual Piper Jaffray Health Care Conference on Tuesday, December 1, 2009 at 9:30am eastern time at the New York Palace Hotel in New York City, NY.
To Discover Injectables Excellence(TM) and learn more about Sagent, please visit www.SagentPharma.com.
CONTACT: Investors, Ronald Pauli of Sagent, +1-847-908-1604; or Media,
Aline Schimmel of WeissComm Partners, +1-312-646-6295, for Sagent
Pharmaceuticals
